Clinical Trial Update: Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluating treatment for pneumonia suspected or confirmed to be due to Pseudomonas aeruginosa has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: Polyphor Ltd. | Conditions: Pneumonia | Phase 3 | Status: TERMINATED